Presentation NY Valves 2024 LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear Presenter: Matteo Sturla June 05, 2024
Presentation NY Valves 2024 Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics Presenter: Amar Krishnaswamy June 05, 2024
Presentation NY Valves 2024 Early Feasibility Studies: How to Enable Innovation While Maintaining Safety Presenter: Aaron V. Kaplan June 05, 2024
Presentation EuroPCR 2024 Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial Presenter: Patrick Serruys May 15, 2024
Presentation EuroPCR 2024 One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II Presenter: Ling Tao May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation EuroPCR 2024 Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis Presenter: Frederik Zimmermann May 15, 2024
Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024
Presentation EuroPCR 2024 Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study. Presenter: Mateusz Tajstra May 15, 2024
Presentation EuroPCR 2024 Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement Presenter: Eliano Navarese May 15, 2024